GINC Technology
Medicines & vaccines · United States

Regeneron Pharmaceuticals

Its Regeneron Genetics Center has sequenced exomes of more than two million people, including UK Biobank, making it one of the largest holders of linked human genetic data.

Headquarters
Tarrytown, United States · North America
Value chain
Medicines & vaccines(Products); also Research & IP
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
1988
Staff
15,106 (2024)
Ownership
Listed
Listing
Nasdaq:REGN on Google Finance
Website
regeneron.com
Relevance
High at its strongest, in Genomics & Biological Data

In 2 capabilities

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Genomics & Biological DataHigh

    Biotechnology & Health Technologies · Operation · listed #11 of 50

    Its Regeneron Genetics Center has sequenced exomes of more than two million people, including UK Biobank, making it one of the largest holders of linked human genetic data.

    Relevance: Regeneron Genetics Center among largest human sequencing efforts

    Source · regeneron.com

  2. Advanced Therapeutics, Vaccines & Medical CountermeasuresHigh

    Biotechnology & Health Technologies · Design · listed #12 of 50

    Rapid-response monoclonal antibody developer: Inmazeb, the first FDA-approved Ebola treatment, and the REGEN-COV COVID-19 antibody cocktail, built with BARDA support.

    Relevance: Rapid-response monoclonal antibody leader

    Source · en.wikipedia.org